Form 8-K - Current report:
SEC Accession No. 0001144204-14-055890
Filing Date
2014-09-15
Accepted
2014-09-15 16:05:25
Documents
17
Period of Report
2014-09-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v389118_8k.htm 8-K 31248
2 EXHIBIT 99.1 v389118_ex99-1.htm EX-99.1 23085
3 GRAPHIC image_001.jpg GRAPHIC 25539
4 GRAPHIC image_002.jpg GRAPHIC 121722
5 GRAPHIC image_003.jpg GRAPHIC 85191
6 GRAPHIC image_004.jpg GRAPHIC 76095
7 GRAPHIC image_005.jpg GRAPHIC 72980
8 GRAPHIC image_006.jpg GRAPHIC 58653
9 GRAPHIC image_007.jpg GRAPHIC 70077
10 GRAPHIC image_008.jpg GRAPHIC 67196
11 GRAPHIC image_009.jpg GRAPHIC 58193
12 GRAPHIC image_010.jpg GRAPHIC 35235
13 GRAPHIC image_011.jpg GRAPHIC 85473
14 GRAPHIC image_012.jpg GRAPHIC 23853
15 GRAPHIC image_013.jpg GRAPHIC 90432
16 GRAPHIC image_014.jpg GRAPHIC 35916
17 GRAPHIC image_015.jpg GRAPHIC 78615
  Complete submission text file 0001144204-14-055890.txt   1415080
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15070 | Film No.: 141103288
SIC: 2834 Pharmaceutical Preparations